BPG is committed to discovery and dissemination of knowledge
Case Report
Copyright: ©Author(s) 2026.
World J Clin Pediatr. Sep 9, 2026; 15(3): 120927
Published online Sep 9, 2026. doi: 10.5409/wjcp.120927
Table 2 Cholesterol, triglycerides and high-density lipoproteins levels at different time points after asparaginase treatment of patient 2
Patient 2Reference intervalBefore PEG-ASP therapyPEG-ASP therapy
Day 12
Day 14
Day 21
Day 31
CHOL (mmol/L)3.10-5.20NA13.393.974.874.99
TG (mmol/L)0.00-1.69NA30.912.504.382.25
HDL (mmol/L)1.17-1.55NA1.170.490.791.32


Write to the Help Desk